Carbamazepine and valproate as adjuncts in the treatment of alcohol withdrawal syndrome: A retrospective cohort study

Alcohol and Alcoholism

Volumn 46, Issue 2, 2011, Pages 177-184

  Eyer, Florian ^a   Schreckenberg, Meike ^a   Hecht, Daniela ^a   Adorjan, Krisztina ^a   Schuster, Tibor ^a   Felgenhauer, Norbert ^a   Pfab, Rudi ^a   Strubel, Tim ^a   Zilker, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CARBAMAZEPINE; CLOMETHIAZOLE; CLONIDINE; COCAINE; OPIATE; VALPROIC ACID;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGRANULOCYTOSIS; ALCOHOL WITHDRAWAL; APLASTIC ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CONSTIPATION; CONTROLLED STUDY; DELIRIUM TREMENS; DIARRHEA; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; HEADACHE; HUMAN; INTENSIVE CARE; JAUNDICE; LENGTH OF STAY; LEUKOCYTOSIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; PANCREATITIS; PANCYTOPENIA; PRIORITY JOURNAL; PRURITUS; PURPURA; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; THROMBOCYTOPENIA; TREATMENT DURATION; URTICARIA; VOMITING; WITHDRAWAL SEIZURE;

EID: 79952010717     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agr005     Document Type: Article

References (57)

1. Ait-Daoud N, Malcolm RJ, Johnson BA. (2006) An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav 31:1628-49.
2. Bastie Y. (1970) Suppression by Depakene of epileptic crises caused by withdrawal in alcoholic detoxification. Ann Med Psychol (Paris) 128:200-4.
3. Bayard M, Mcintyre J, Hill KR et al. (2004) Alcohol withdrawal syndrome. Am Fam Physician 69:1443-50.
4. Bocci U, Beretta G. (1976) Experience with sodium dipropylacetate in alcoholics and cases of drug addiction. Lav Neuropsychiatr 58:51-6.
5. Bonnet U, Schafer M, Richter C et al. (2009) [Anticonvulsants in the treatment of alcoholism]. Fortschr Neurol Psychiatr 77:192-202.
6. Brathen G, Ben-Menachem E, Brodtkorb E et al. (2005) EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurol 12:575-81.
7. Brewer C. (1995) Second-line and 'alternative' treatments for alcohol withdrawal: alpha-agonists, beta-blockers, anticonvulsants, acupuncture and neuro-electric therapy. Alcohol Alcohol 30:799-803.
8. Brune F, Busch H. (1971) Anticonvulsive-sedative treatment of delirium alcoholicum. Q J Stud Alcohol 32:334-42.
9. Croissant B, Loeber S, Diehl A et al. (2009) Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal-a RCT. Pharmacopsychiatry 42:175-81.
10. De Sousa A. (2010) The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review. CNS Neurol Disord Drug Targets 9:45-9.
11. De Witte P, Pinto E, Ansseau M et al. (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189-97.
12. Dodd PR, Beckmann AM, Davidson MS et al. (2000) Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 37:509-33.
13. Ferguson JA, Suelzer CJ, Eckert GJ et al. (1996) Risk factors for delirium tremens development. J Gen Intern Med 11:410-4.
14. Gilman S, Koeppe RA, Adams K et al. (1996) Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 40:163-71.
15. Glue P, Nutt D. (1990) Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. Br J Psychiatry 157:491-9.
16. Gonzalez LP, Veatch LM, Ticku MK et al. (2001) Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcohol Clin Exp Res 25:197S-201.
17. Gorelick DA, Wilkins JN. (1986) Special aspects of human alcohol withdrawal. Recent Dev Alcohol 4:283-305.
18. Hammer BA, Brady KT. (1996) Valproate treatment of alcohol withdrawal and mania. Am J Psychiatry 153:1232.
19. Hillbom M, Tokola R, Kuusela V et al. (1989) Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol 6:223-6.
20. Hirschfeld RM, Allen MH, Mcevoy JP et al. (1999) Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 60:815-8.
21. Johnson BA, Rosenthal N, Capece JA et al. (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641-51.
22. Krebs M, Leopold K, Richter C et al. (2006) Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial. J Clin Psychopharmacol 26:347-9.
23. Lambie DG, Johnson RH, Vijayasenan ME et al. (1980) Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 14:213-5.
24. Longo LP, Campbell T, Hubatch S. (2002) Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis 21:55-64.
25. Lucht M, Kuehn KU, Armbruster J et al. (2003) Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol Alcohol 38:168-75.
26. Lum E, Gorman SK, Slavik RS. (2006) Valproic acid management of acute alcohol withdrawal. Ann Pharmacother 40:441-8.
27. Malcolm R, Myrick H, Brady KT et al. (2001) Update on anticonvulsants for the treatment of alcohol withdrawal. Am J Addict 10 (Suppl.):16-23.
28. Malcolm R, Myrick H, Roberts J et al. (2002) The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 17:349-55.
29. Mayo-Smith MF. (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 278:144-51.
30. Mayo-Smith MF, Beecher LH, Fischer TL et al. (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164:1405-12.
31. Minozzi S, Amato L, Vecchi S et al. (2010) Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 3:CD005064.
32. Minuk GY, Rockman GE, German GB et al. (1995) The use of sodium valproate in the treatment of alcoholism. J Addict Dis 14:67-74.
33. Mueller TI, Stout RL, Rudden S et al. (1997) A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol Clin Exp Res 21:86-92.
34. Muller CA, Schafer M, Schneider S et al. (2010) Efficacy and safety of levetiracetam for outpatient alcohol detoxification. Pharmacopsychiatry 43:184-9.
35. Myrick H, Anton RF. (1998) Treatment of alcohol withdrawal. Alcohol Health Res World 22:38-43.
36. Nutt D. (1999) Alcohol and the brain. Pharmacological insights for psychiatrists. Br J Psychiatry 175:114-9.
37. Patsalos PN, Perucca E. (2003) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2:473-81.
38. Perucca E. (2006) Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 61:246-55.
39. Polycarpou A, Papanikolaou P, Ioannidis JP et al. (2005) Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev 3:CD005064.
40. Powell G, Saunders M, Marson AG. (2010) Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Cochrane Database Syst Rev 1:CD007124.
41. Rathlev NK, Ulrich AS, Delanty N et al. (2006) Alcohol-related seizures. J Emerg Med 31:157-63.
42. Reoux JP, Saxon AJ, Malte CA et al. (2001) Divalproex sodium in alcohol withdrawal: a randomized double-blind placebocontrolled clinical trial. Alcohol Clin Exp Res 25:1324-9.
43. Ritola E, Malinen L. (1981) A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 64:254-9.
44. Rosenthal RN, Perkel C, Singh P et al. (1998) A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict 7:189-97.
45. Saitz R. (1995) Recognition and management of occult alcohol withdrawal. Hosp Pract (Minneap) 30:49-4, 56-8.
46. Sanna E, Talani G, Busonero F et al. (2004) Brain steroidogenesis mediates ethanol modulation of GABAA receptor activity in rat hippocampus. J Neurosci 24:6521-30.
47. Schuckit MA, Tipp JE, Reich T et al. (1995) The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction 90:1335-47.
48. Seifert J, Peters E, Jahn K et al. (2004) Treatment of alcohol withdrawal: chlormethiazole vs. carbamazepine and the effect on memory performance-a pilot study. Addict Biol 9:43-51.
49. Stuppaeck CH, Pycha R, Miller C et al. (1992) Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol 27:153-8.
50. Sullivan JT, Sykora K, Schneiderman J et al. (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-7.
51. Tsai G, Coyle JT. (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173-84.
52. Tsai G, Gastfriend DR, Coyle JT. (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332-40.
53. Victor M. (1966) Treatment of the neurologic complications of alcoholism. Mod Treat 3:491-501.
54. Wetterling T, Kanitz RD, Besters B et al. (1997) A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale). Alcohol Alcohol 32:753-60.
55. Wetterling T, Driessen M, Kanitz RD et al. (2001) The severity of alcohol withdrawal is not age dependent. Alcohol Alcohol 36:75-8.
56. Wilbur R, Kulik FA. (1981) Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anticonvulsants. Am J Hosp Pharm 38:1138-43.
57. Wojnar M, Bizon Z, Wasilewski D. (1999) The role of somatic disorders and physical injury in the development and course of alcohol withdrawal delirium. Alcohol Clin Exp Res 23:209-13.